Search for: "Mylan Pharmaceuticals"
Results 81 - 100
of 738
Sorted by Relevance
|
Sort by Date
1 Aug 2010, 9:59 pm
• Defendant: Mylan Pharmaceuticals Inc. [read post]
10 Jan 2012, 12:43 pm
Mamula, Reporter for the Pittsburgh Business Times: Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs have sued generic drugmaker Mylan Inc. for patent infringement in connection with its plans to market pioglitazone hydrochloride and extended release metformin hydrochloride tablets, Canonsburg-based Mylan announced Monday. [read post]
16 Jun 2007, 7:17 am
Mylan Laboratories Inc., Mylan Pharmaceuticals Inc. and UDL Laboratories Inc. v. [read post]
21 Jul 2022, 9:15 am
Mylan Pharmaceuticals Inc. [read post]
21 Jul 2022, 9:15 am
Mylan Pharmaceuticals Inc. [read post]
4 Mar 2012, 8:24 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
29 Jan 2012, 8:59 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
10 Aug 2011, 8:59 am
Mylan Pharmaceuticals Inc., C.A. [read post]
5 Sep 2017, 7:45 am
According to DOJ’s press release: Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed primarily to Medicaid, the Justice Department announced today. [read post]
25 May 2012, 11:32 am
Mylan Pharmaceuticals Inc., C.A. [read post]
13 Sep 2010, 9:59 pm
., Mylan Inc., Mylan Laboratories, Inc., and Mylan Pharmaceuticals, Inc. [read post]
6 Nov 2023, 1:15 pm
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
30 Sep 2013, 4:50 am
Mark Lemley's Firm Files DJ Against Myriad in Northern California ----- Promise Not to Infringe Insufficient in ANDA Litigation ----- Licensing Deals Stall in Pharmaceutical Sector in First Half of 2013 ----- Mylan Settles with FTC over Agila Acquisition from Strides ----- Amgen and ShanghaiTech University Announce China R&D Center ----- Forest Laboratories sues over SAVELLA® generics ----- Teva Pharmaceutical scores patent cictory over Mylan on… [read post]
6 Nov 2023, 1:15 pm
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
20 Jun 2010, 8:51 pm
LLC; Sugen Inc.; C P Pharmaceuticals International CV • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
27 Feb 2011, 8:59 pm
Mylan Inc. et al. 1:11-cv-01285; filed February 23, 2010 in the Northern District of Illinois • Plaintiff: The Medicines Company • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc.; Bioniche Pharma USA, LLC Infringement of U.S. [read post]
30 Dec 2021, 8:07 am
Mylan Pharmaceuticals Inc., November 30, 2021, Reyna, J.). [read post]
5 Feb 2014, 9:21 am
Mylan Pharmaceuticals Inc., Civ. [read post]
9 Jul 2010, 3:24 pm
As one of the leading manufacturers of generic drugs in the world, Mylan received final approval by the Food and Drug Administration (FDA) in 2009 to manufacture a generic substitute for the anti-seizure medication, Keppra, developed by UCB Pharmaceuticals Inc. and marketed to epilepsy patients. [read post]
11 Apr 2010, 9:36 pm
• Defendant: Mylan Pharmaceuticals Inc. [read post]
